Abstracts (HTML) List of Authors

Haas, T

The need for psychological and psychotherapeutic interventions in Austrian patients with inflammatory bowel disease

Hackl, M

Factors associated with the presence of cirrhotic cardiomyopathy defined according to the new Multidisciplinary Diagnostic Criteria

Haens, G

Clinical and endoscopic response to ustekinumab in Crohn’s disease: Week 16 interim analysis of the STARDUST trial

Halilbasic, E

Features of the portal hypertensive syndrome in patients with advanced PBC
Durable Response in the Markers of Cholestasis Through 5 Years of Open-Label Extension Study of Obeticholic Acid in Primary Biliary Cholangitis

Haltmayer, H

Achieving hepatitis C elimination in people who inject drugs - interim results of an innovative screen-and-treat program in Austria
Directly observed therapy for hepatitis C with sofosbuvir/velpatasvir alongside opioid substitution as an effective micro elimination strategy in PWIDs at high risk of non-adherence to antiviral therapy - real world data from Vienna, Austria

Hartl, L

Humoral biomarkers of hemodynamic derangement in distinct stages of portal hypertension
Beta blocker therapy seems to reduce systemic inflammation in cirrhotic patients with portal hypertension - a paired HVPG study

Haselmann, C

Personalisierte Ernährungsmedizin am Beispiel einer Patientin mit Propionazidämie

Hempel, D

Antitumor activity of larotrectinib in esophageal carcinoma with NTRK gene amplification

Hempel, L

Antitumor activity of larotrectinib in esophageal carcinoma with NTRK gene amplification

Henninger, B

Neurodegenerative patterns in Wilson disease with hepatic or neurological manifestation assessed by morphometric magnetic resonance imaging

Hernández-Gea, V

SVR to DAA does not affect the risk of portal vein thrombosis in patients with advanced chronic liver disease

Hinterberger, A

Impact of lesion phenotype on colorectal cancer mortality and overall mortality: insights from a nationwide screening colonoscopy program

Hisamatsu, T

Efficacy of Ustekinumab for Ulcerative Colitis Through 2 Years: Results of the UNIFI Maintenance Study and Long-term Extension

Hofer, B

Personalisierte Ernährungsmedizin am Beispiel einer Patientin mit Propionazidämie

Högenauer, C

Die Endosonographie-gezielte Gastroenterostomie bei maligner Magenausgangsstenose - erste Erfahrungswerte

Hoppe, R

Endoskopische Raritäten - eine kleine Sammlung.

Horvath, A

Where have all the women gone? - Die Repräsentation von Frauen in der Gastroenterologie und Hepatologie in Österreich
Die Auswirkungen eines multispezies-Synbiotikums auf Mikrobiom-assoziierte Nebenwirkungen einer Langzeit-Protonen-Pumpen-Hemmer Therapie: Eine Pilotstudie
Dysbiosis in dementia is associated with gut barrier dysfunction and linked to malnutrition and prescription drug use
Fibroscan® probe selection for lean adults
Increased resting respiratory burst and decreased phagocytosis and chemotaxis: how bile acids impair neutrophil response in liver cirrhosis

Horvath A, Stadlbauer V

The use of and knowledge about proton pump inhibitors in the general population of Austria

Huber-Schönauer, U

The natural course of anti-mitochondrial antibody positive subjects is similar in confirmatory immunoblot-M2 positive and negative subjects
Screening for chronic liver diseases in the general population reveals an unexpectedly high prevalence of hepatitis c and advanced NAFLD
Effect of nut consumption on prevalence and severity of NAFLD, cardiovascular diseases and metabolic disorders
NAFLD in lean patients is associated with an increased cardiovascular risk, prediabetes and the metabolic syndrome
Alcohol consumption and the risk for colorectal adenoma
Should colonoscopy screening recommendations be sex-specific and age adjusted?

Hucke, F

Elevation of liver enzyme under immunotherapy with checkpoint inhibitors
Challenges in hepatitis C elimination despite highly effective antiviral agents - experience of a tertiary Hepatology center